Q4 2024 Management View CEO Yehiel Tal highlighted advancements in CollPlant's proprietary photocurable dermal filler, emphasizing its potential as a game-changer in the $6.3 billion market for ...
Islanders are being warned about the risks of having non-surgical cosmetic treatments like dermal fillers from people who are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback